Copel seeks Latibex delisting, awaits BME approval
ELP•Copel board approves Latibex delisting request
Copel’s board cleared a request to delist its shares from Latibex, a segment of the Madrid Stock Exchange.
The move aligns with a corporate simplification strategy.
Delisting completion remains subject to BME/Latibex review, approval, and ratification, with timing still pending.
Trading will continue on B3 and the NYSE.
Related News
CO2 Energy Transition shifts Nasdaq listing to Capital Market after continued listing rule issue
NOEM•
PACS Group President, COO Joshua Jergensen disposes of $1.73 million in common shares
PACS•
